Janus Henderson Group’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Janus Henderson Group’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-67,675	Closed	-$2.78M	–	1446
2020 Q3	$2.78M	Sell	67,675 -40,420	-37%	-$2.09M	﹤0.01%	1001
2020 Q2	$6.49M	Buy	108,095 +10,206	+10%	+$935K	﹤0.01%	883
2020 Q1	$7.37M	Buy	97,889 +96,340	+6,219%	+$11.1M	0.01%	851
2019 Q4	$213K	Buy	+1,549	New	+$188K	﹤0.01%	1389

Other funds holding ORTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Janus Henderson Group's ORTX Position: Q4 2020 in Review

Janus Henderson Group sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2020, closing a stake of 67,675 shares — an estimated $2.78M sold.

Janus Henderson Group first reported a position in ORTX in Q4 2019 and held it in 4 quarters. The position peaked at $7.37M in Q1 2020. 77 funds tracked by Wall St. Rank hold ORTX as of Q4 2020.

Janus Henderson Group reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
Janus Henderson Group sold 67,675 Orchard Therapeutics plc American Depositary Shares shares in Q4 2020, an estimated $2.78M.
Janus Henderson Group first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2019 and held it in 4 quarters.
Janus Henderson Group's Orchard Therapeutics plc American Depositary Shares position peaked at $7.37M in Q1 2020.
77 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2020.

Based on Janus Henderson Group's 13F filing for Q4 2020, filed 16 Feb 2021.